Albrecht H.
- Country
- Germany
- Department
- Oncology,Gastroenterology,Hepatology,Pulmonology and Infectiology
Research Overview
- Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ANB033 in Patients with Celiac Disease
- Cholangiocarcinoma treatment with radiofrequency ablation or photodynamic therapy
- Efficacy and Safety Evaluation of Barzolvolimab in Adults with Active Eosinophilic Esophagitis: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 28 of 121 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating complex gastrointestinal cancers, with particular focus on cholangiocarcinoma and pancreatic ductal adenocarcinoma. Their research explores innovative therapeutic approaches including radiofrequency ablation and photodynamic therapy for bile duct cancers.
- Hilar Cholangiocarcinoma Management
- Pancreatic Cancer Treatment Optimization
- Post-surgical Cancer Care
Digestive Disorders
The investigator focuses on treating complex digestive system conditions, including gastroparesis and celiac disease. Their work encompasses both idiopathic and diabetic-related gastrointestinal disorders, with emphasis on symptom management and therapeutic interventions.
- Gastroparesis Treatment
- Celiac Disease Management
- Post-Gastrectomy Care
Esophageal Conditions
The investigator has developed expertise in treating eosinophilic esophagitis, exploring novel therapeutic approaches and long-term treatment solutions. Their research includes evaluation of innovative medications for managing esophageal conditions.
- Eosinophilic Esophagitis Treatment
- Mast Cell Infiltration Studies
- Long-term Disease Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.